National Pharma Audioconference: Overview and Implications of PhRMA's DTC Drug Marketing Guidelines
Tuesday, September 13, 2005
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)
Diane E. Bieri, Esq.
Acting General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, DC
Janet L. "Lucy" Rose, MBA
President, Lucy Rose and Associates, Former Director, Division of Drug Marketing Advertising, and Communications (DDMAC) and Former Director, Office of Training and Communications, Center for Drug Evaluation and Research (CDER), Food and Drug Administration, Washington, DC
Executive Vice President, Managing Director, McCann HumanCare, McCann Erickson New York, A McCann Worldgroup Company, New York, NY
Daniel E. Troy, Esq.
Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel. Food and Drug Administration, Washington, DC
John T. Bentivoglio, Esq.
Partner, King & Spalding, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC (Moderator)
SAVE THE DATE!
THE FIFTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS|
Sponsored by Pharmaceutical Compliance Forum and PricewaterhouseCoopers
November 6-9, 2005
- Click here for more info -